0 followers
n-Lorem’s mission is to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotides (ASO) medicines to treat patients with ultra-rare diseases (<10 patients).
Stanley T. Crooke
SmithBucklin
2 followers
American Red Cross
21 followers
Ozark Frontier Outdoor Ventures, LLC
1 follower
Jovian
2 followers
Wipro
381 followers
PepsiCo
348 followers
Charles Schwab
214 followers
Cognizant
167 followers
Bristol-Myers Squibb
175 followers
BNY Mellon
166 followers
Raytheon Technologies
161 followers
Explore companies